# US 2015/0104498 A1 · Compositions and kits for the removal of irritating compounds from bodily surfaces

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104498 A1
- Document ID: US20150104498A1
- Status: Published application
- Kind: A1
- Application number: 14/542,041
- Filed: 2014-11-14
- Published: 2015-04-16
- Earliest claimed: 2002-09-05
- Assignees: Acorda Therapeutics, Inc.
- Applicants: Acorda Therapeutics, Inc.
- Inventors: Arturo J. ANGEL; Larry W. LITLE; Keith R. BLEY; Allan L. WILCOX; Gene C. JAMIESON; Naweed MUHAMMAD
- Web page: https://patentgrep.com/patent/US20150104498A1

## CPC

- A61K 8/86: Polyethers
- A61K 8/33: containing oxygen
- A61K 8/42: Amides
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K 8/8152: {Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/7084: {Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches}
- A61K 31/16: Amides, e.g. hydroxamic acids
- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- A61P 17/00: Drugs for dermatological disorders
- A61P 23/00: Anaesthetics
- A61P 23/02: Local anaesthetics
- A61P 25/02: for peripheral neuropathies
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61Q 17/00: Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q 19/10: Washing or bathing preparations
- A61K 2800/75: Anti-irritant
- A61K 2800/88: Two- or multipart kits
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The invention provides compositions, methods and kits for the removal of harmful or irritating substances from bodily surfaces. Kits may include a composition containing capsaicin and a capsaicin-cleansing composition, e.g., a composition in which capsaicin is soluble.

## Claims

### Claim 1

A kit, comprising:
a) a first composition comprising capsaicin or a capsaicin analog; and
b) a second composition comprising a substance in which the capsaicin or capsaicin analog is soluble.

### Claim 2 (depends on 1)

The kit of claim 1 wherein the second composition comprises a substance in which said capsaicin or analog has a solubility of at least about 10 percent w/w.

### Claim 3 (depends on 1)

The kit of claim 1 wherein the second composition comprises a substance in which said capsaicin or analog has a solubility of at least about 20 percent w/w.

### Claim 4 (depends on 1)

The kit of claim 1 wherein the second composition comprises a substance in which capsaicin or analog has a solubility of at least about 25 percent w/w.

### Claim 5 (depends on 1)

The kit of claim 1 wherein the second composition comprises polyethylene glycol and a polyacrylate thickening polymer.

### Claim 6 (depends on 1)

The kit of claim 1 wherein the second composition comprises:
a) about 60 to about 99 percent w/w polyethylene glycol (PEG);
b) about 0.1 to about 4.0 percent w/w polyacrylate thickening agent; and
c) the balance water; wherein the composition is at a pH between about 6.0 and about 8.0.

### Claim 7 (depends on 6)

The kit of claim 6 wherein the second composition comprises
a) about 84 to about 94 percent w/w polyethylene glycol;
b) about 0.1 to about 2.0 percent w/w polyacrylate thickening agent; and
c) the balance water; wherein the composition is at a pH of about 7.0 to 7.5.

### Claim 8 (depends on 7)

The kit of claim 7 wherein the second composition further comprises:
d) about 0.005 to about 0.05 percent w/w butylated hydroxyanisole; and
e) about 0.05 to about 0.5 percent w/w edetate sodium.

### Claim 9 (depends on 1)

The kit of claim 1 further comprising a third composition, wherein said third composition comprises an anesthetic.

### Claim 10 (depends on 1)

The kit of claim 1 further comprising instructions for use.

### Claim 11 (depends on 1)

The kit of claim 1 wherein the first composition comprises capsaicin or a capsaicin analog at a concentration of about 0.001 to about 60 percent w/w.

### Claim 12 (depends on 1)

The kit of claim 1 wherein the first composition comprises capsaicin or a capsaicin analog at a concentration of about 1.0 to about 10 percent w/w.

### Claim 13 (depends on 1)

The kit of claim 1 wherein the first composition comprises capsaicin or a capsaicin analog at a concentration of about 5 to about 10 percent w/w.

### Claim 14 (depends on 1)

The kit of claim 1 wherein the first composition comprises capsaicin or a capsaicin analog contained in a patch.

### Claim 15 (depends on 14)

The kit of claim 14 wherein the capsaicin or analog is present in the patch at an amount of about 0.64 mg/cm2.

### Claim 16

A kit, comprising:
a) a first composition comprising a patch comprising capsaicin or capsaicin analog at an amount of about 0.64 mg/cm2;
b) a second composition comprising a cleansing gel comprising:
i) about 84 to about 94 percent w/w polyethylene glycol;
ii) about 0.1 to about 2.0 percent w/w polyacrylate thickening agent; and
iii) about 0.005 to about 0.05 percent w/w butylated hydroxyanisole;
iv) about 0.05 to about 0.5 percent w/w edetate sodium; and
v) the balance water; wherein the second composition is at a pH of about 7.0 to 7.7.

### Claim 17

A composition for cleansing a bodily surface comprising:
a) about 60 to about 99 percent w/w polyethylene glycol (PEG);
b) about 0.1 to about 4.0 percent w/w polyacrylate thickening agent; and
c) the balance water; wherein the composition is at a pH between about 6.0 and about 8.0.

### Claim 18 (depends on 17)

The composition of claim 17 comprising:
a) about 84 to about 94 percent w/w polyethylene glycol (PEG);
b) about 0.1 to about 2.0 percent w/w polyacrylate thickening agent; and
c) the balance water; wherein the composition is at a pH between about 7.0 and about 7.7.

### Claim 19 (depends on 18)

The composition of claim 18 further comprising a stabilizer.

### Claim 20 (depends on 19)

The composition of claim 19 further comprising a cooling agent.

### Claim 21 (depends on 19)

The composition of claim 19 comprising:
a) about 87 to about 91 percent w/w polyethylene glycol;
b) about 0.3 to about 1.5 percent w/w polyacrylate thickening agent;
c) about 0.01 to about 0.03 percent w/w butylated hydroxyanisole;
d) about 0.02 to about 0.2 percent w/w edetate sodium; and
e) the balance water; wherein the composition is at a pH of about 7.0 to about 7.7.

### Claim 22 (depends on 21)

The composition of claim 21 comprising
a) about 89.08 percent w/w PEG 300;
b) about 1.0 percent w/w polyacrylate thickening agent;
c) about 0.02 percent w/w butylated hydroxyanisole;
d) about 0.1 percent w/w disodium edetate; and
e) the balance water; wherein the composition is at a pH of about 7.5.

### Claim 23

A method for treating pain in an individual in an area of the body affected by pain, comprising:
a) administering an afferent nerve fiber blocking regional anesthetic to the affected area;
b) affixing to the affected area a device, wherein said device comprises a skin-adherent patch, the patch including a reservoir comprising a therapeutic formulation whereby said formulation is continuously provided to the surface of the skin for a predetermined period of time, wherein said formulation comprises capsaicin or a capsaicin analog in a total concentration from greater than about 5% to 10% by weight of the formulation, wherein a single administration of said patch affords significant relief of said pain to said individual for at least several weeks; and
c) cleansing the area to which the patch of step b) has been applied by
i) applying to the area a composition comprising about 80 to about 99 percent w/w polyethylene glycol; about 0.1 to about 2.0 percent w/w polyacrylate thickening agent; and the balance water; wherein the composition is at a pH of about 7.0 to about 7.7; and
ii) removing the composition of step (c) from the area.

### Claim 24

A method for cleansing a bodily surface that has been contacted with an irritating or painful substance, comprising:
a) applying to the bodily surface a composition comprising:
i) about 80 to about 99 percent w/w polyethylene glycol;
ii) about 0.1 to about 2.0 percent w/w polyacrylate thickening agent; and
iii) the balance water; wherein the composition is at a pH of about 7.0 to about 7.7; and
b) removing the composition of step (a) from the bodily surface.
